Peripheral intervention devices include stents, sheaths, and guidewires, among others. Due to their non-invasive nature, peripheral interventions provide greater treatment efficiency, thus assisting in managing cardiovascular diseases over the period. Peripheral intervention devices help restore the flow of blood to the other end of the arteries, where the blood clot or plaque formation has prevented the flow of oxygenated blood to circulate in the body. Peripheral intervention procedures require the use of a catheter that is inserted via a thin cut in an artery, usually in an arm, shoulder, or leg. They are then directed to the site of blockage/lesion/damage with the assistance of an x-ray angiogram, or other device. The catheter is then used to eradicate the blockage by either creating a tunnel through a balloon or by introducing a stent made of Nitinol or any other high-grade metal composites. If a balloon is used, then it is removed after it is deflated; if a stent is used, it then remains in the artery in order to support the arterial wall.
MARKET DYNAMICS
The peripheral intervention devices market has shown a significant evolution over the forecast period. The rise of the peripheral intervention devices market is majorly driven by the high incidence rate of cardiovascular disorders and the rising prevalence of cerebrovascular disease and peripheral artery disease (PAD). Various risk factors like smoking, unhealthy lifestyle, atherosclerosis, and hypertension will further contribute to peripheral intervention devices market growth. Moreover, due to comorbidities of peripheral artery disease and complexities, balloon angioplasty and stenting devices will foresee significant demand in the upcoming years. Additionally, rapidly advancing technologies in vascular intervention systems will yield competitive market growth opportunities. Leading market players offering advanced minimally invasive devices such as drug-eluting stents, drug-coated balloons, catheters, guidewires, etc., coupled with superior benefits, have substantially increased the procedural success rate. For instance, Xience Sierra introduced by Abbott is the newest stent technology, offering various benefits such as flexibility, extended length, small diameter, and more excellent compatibility. However, the occurrence of stent thrombosis is likely to restrain the market growth.
MARKET SCOPE
The "Peripheral Intervention Devices Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry's medical device, with a specific focus on the global market trend analysis. This report provides an outline of the peripheral intervention devices market with detailed market segmentation by product, application, and end-user. The peripheral intervention devices market is estimated to witness high growth during the forecast period. It focuses on the vital statistics on the leading players' market status in the peripheral intervention devices market and offers key opportunities and trends in the market.
MARKET SEGMENTATION
The market is categorized based on the product, application, and end user. Based on the product, the market is segmented as peripheral vascular stents, peripheral transluminal angioplasty balloon catheters, PTA guidewires, atherectomy devices, and others. Based on the application, the segmentation of the market is into vascular, oncology procedures, neurology, renal, and others. Based on end user, segmentation of the market is into hospitals, catheterization laboratories, ambulatory surgical centers, and others.
REGIONAL FRAMEWORK
The report states a detailed outline of the industry, consisting of both qualitative and quantitative information. It gives a sketch and forecast of the peripheral intervention devices market based on various segments. The report also consists of market size and forecast estimates from the year 2020 to2028with respect to five primary regions, namely; North America, Asia-Pacific (APAC), Europe, Middle East, and Africa (MEA), and South & Central America (SCAM). The peripheral intervention devices market by each region is then subdivided into respective countries and segments. It offers the analysis and forecast of 18 countries worldwide and the recent trend and opportunities prevailing in the region.
The report analyzes factors affecting the peripheral intervention devices market from both the demand and supply sides. Furthermore, it assesses market dynamics affecting the market during the forecast period, i.e., drivers, restraints, opportunities, and future trends. It also comprises a precise PEST analysis for all five regions, namely, North America, APAC, Europe, MEA, and South & Central America, after evaluating political, social, economic, and technological factors affecting the peripheral intervention devices market in these regions.
MARKET PLAYERS
The report contains critical developments in the peripheral intervention devices market as inorganic and organic growth strategies. Various companies are pivoting on organic growth strategies like product approvals, product launches, and others, such as events and patents. Inorganic growth strategies noticed in the market were acquisitions and collaborations &partnerships. Such activities have paved the path for the expansion of the business and customer base of market players. The market players from the peripheral intervention devices market are anticipated to have profitable growth opportunities in the following years with the increasing demand for peripheral intervention devices in the global market. Below mentioned is the list of a few companies engaged in the peripheral intervention devices market.
The report also offers key players' profiles in the peripheral intervention devices market, along with their SWOT analysis and market strategies. Also, the report focuses on leading market players with information on company profiles, financial information of the last three years, components, and services provided, critical development in the past five years.
- Abbott.
- Cook
- Cardinal Health. (Cordis)
- Boston Scientific Corporation
- C.R. Bard Inc.
- Medtronic
- Terumo Medical Corporation
- Teleflex Incorporated.
- Bayer AG
- BD
The Insight Partner's dedicated research and analysis team comprises of experienced professionals with advanced statistical expertise and offers various customization options in the current study.